✦ LIBER ✦

An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

✍ Scribed by A Awada; R Thödtmann; M.J Piccart; J Wanders; A.H.G.J Schrijvers; I.-M Von Broen; A.R Hanauske

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and pharmacoklnetic evaluation

✍ Thōdtmann, R.; Awada, A.; Piccart, M.; Höppener, F.; Wanders, J.; von Broen, I.- 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 387 KB

A phase I study of bendamustine hydrochl

✍ Rasschaert, M; Schrijvers, D; Van den Brande, J; Dyck, J; Bosmans, J; Merkle, K; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase I study and pharmacokinetic of CHS

✍ Alain Ravaud; Thomas Cerny; Catherine Terret; Jantien Wanders; Binh Nguyen Bui; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase I and pharmacokinetic study of Yon

✍ C. Twelves; K. Hoekman; A. Bowman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Phase I clinical and pharmacokinetic stu

✍ C Terret; S Zanetta; H Roché; J.H.M Schellens; M.N Faber; J Wanders; M Ravic; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

1486 PUBLICATION A phase I combination s

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB